Sugammadex: Clinical Trials

5 trials for Sugammadex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Unknown 2

Follow Sugammadex: new trials by email Literature Review of Sugammadex trials Research Report on Sugammadex

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
Neostigmine, Sugammadex - Urinary Retention Postoperative, Laparoscopic Cholecystectomy
Phase 4CompletedUniversity of Texas Southwestern Medical Center2352023-09-112024-10-09
Neostigmine Versus Sugammadex on Renal Functions
Neostigmine, Sugammadex - Sugammadex, Neostigmine
Phase 4UnknownMenoufia University642023-03-012023-10-13
Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex
sugammadex - Diaphragm Ultrasonography, Liver Dysfunction
Phase 4UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology992021-07-012021-09-05
Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine
Sugammadex, Neostigmine - Neuromuscular Blockade Reversal Agent, Sugammadex
Phase 4CompletedSeoul National University Bundang Hospital772020-02-242020-12-24
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
Neostigmine, Sugammadex - Neuromuscular Blockade, Sugammadex
Phase 4CompletedKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital1132013-05-012021-10-04

Narrower conditions

Delayed Emergence from Anesthesia (1)  ·  Liver Diseases (1)

Broader conditions

Digestive System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)

Interventions

Sugammadex (5)  ·  Neostigmine (4)

Sponsors

Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital (1)  ·  Menoufia University (1)  ·  Seoul National University Bundang Hospital (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

China (1)  ·  Egypt (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Jiwon Han, Ms (1)  ·  Tiffany Moon, MD (1)  ·  Yun Lin, MD, PhD. (1)

Results publications

PMID 20876699, PMID 20885293, PMID 26634077, PMID 28399799, PMID 35105573, PMID 38686365, PMID 41789933